Cargando…

Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer

BACKGROUND: To quantify the dosimetric parameters of different bone marrow sparing strategies and to determine the optimal strategy for cervical cancer patients undergoing postoperative intensity-modulated radiotherapy (IMRT). METHODS: Fifteen patients with cervical cancer were selected for analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Zhirong, Wang, Dajiang, Chen, Shupeng, Chen, Min, Jiang, Dazhen, Yang, Chunxu, Liu, Hui, Dai, Jing, Xie, Conghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681496/
https://www.ncbi.nlm.nih.gov/pubmed/31378200
http://dx.doi.org/10.1186/s13014-019-1324-y
_version_ 1783441740768739328
author Bao, Zhirong
Wang, Dajiang
Chen, Shupeng
Chen, Min
Jiang, Dazhen
Yang, Chunxu
Liu, Hui
Dai, Jing
Xie, Conghua
author_facet Bao, Zhirong
Wang, Dajiang
Chen, Shupeng
Chen, Min
Jiang, Dazhen
Yang, Chunxu
Liu, Hui
Dai, Jing
Xie, Conghua
author_sort Bao, Zhirong
collection PubMed
description BACKGROUND: To quantify the dosimetric parameters of different bone marrow sparing strategies and to determine the optimal strategy for cervical cancer patients undergoing postoperative intensity-modulated radiotherapy (IMRT). METHODS: Fifteen patients with cervical cancer were selected for analysis. The planning target volume (PTV) and the organs at risks (OAR) including small bowel, bladder, rectum, femoral heads, os coxae (OC), lumbosacral spine (LS) and bone marrow (BM) were contoured. For each patient, four IMRT plans with different strategies were generated, including one plan without BM as the dose-volume constraint, namely IMRT (N) plan, and three bone marrow sparing (BMS-IMRT) plans. The three BMS-IMRT plans used the BM, OC, OC and LS respectively, as the BM OAR, namely as IMRT (BM), IMRT (OC) and IMRT (OC + LS) plans. Dose volumes for the target and the OARs were compared using analysis of variance (ANOVA). RESULTS: Compared with IMRT (N) plans, the dose to the small bowel, bladder, rectum and femoral heads showed no increase in the three BMS-IMRT plans. However, the irradiated dose to BM, OC and LS significantly decreased. In particular, the mean dose of BM, OC and LS decreased by about 5Gy (p < 0.05) in IMRT (BM) plans while the average volume receiving ≥20, ≥30, ≥40Gy decreased by 7.1–24.2%. The LS volume receiving 40Gy showed the highest decrease (about 31.2%, p < 0.05) in IMRT (OC + LS) plans. On the other hand, in comparison with IMRT (BM), IMRT (OC) reduced the dose volume of to the OC, but increased the dose to LS while IMRT (OC + LS) plans reduced both the OC and the LS volume at all dose levels. Specifically, the V(20) of OC and LS in the IMRT (OC + LS) plan decreased by 11.5 and 11.2%, respectively. CONCLUSION: By introducing the os coxae and lumbosacral spine as the dose–volume constraints, the IMRT plans exhibited the best sparing of the bone marrow without compromising the dose to surrounding normal structures. Therefore, we recommend adding the os coxae and lumbosacral spine as the BM OAR in such plans.
format Online
Article
Text
id pubmed-6681496
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66814962019-08-07 Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer Bao, Zhirong Wang, Dajiang Chen, Shupeng Chen, Min Jiang, Dazhen Yang, Chunxu Liu, Hui Dai, Jing Xie, Conghua Radiat Oncol Research BACKGROUND: To quantify the dosimetric parameters of different bone marrow sparing strategies and to determine the optimal strategy for cervical cancer patients undergoing postoperative intensity-modulated radiotherapy (IMRT). METHODS: Fifteen patients with cervical cancer were selected for analysis. The planning target volume (PTV) and the organs at risks (OAR) including small bowel, bladder, rectum, femoral heads, os coxae (OC), lumbosacral spine (LS) and bone marrow (BM) were contoured. For each patient, four IMRT plans with different strategies were generated, including one plan without BM as the dose-volume constraint, namely IMRT (N) plan, and three bone marrow sparing (BMS-IMRT) plans. The three BMS-IMRT plans used the BM, OC, OC and LS respectively, as the BM OAR, namely as IMRT (BM), IMRT (OC) and IMRT (OC + LS) plans. Dose volumes for the target and the OARs were compared using analysis of variance (ANOVA). RESULTS: Compared with IMRT (N) plans, the dose to the small bowel, bladder, rectum and femoral heads showed no increase in the three BMS-IMRT plans. However, the irradiated dose to BM, OC and LS significantly decreased. In particular, the mean dose of BM, OC and LS decreased by about 5Gy (p < 0.05) in IMRT (BM) plans while the average volume receiving ≥20, ≥30, ≥40Gy decreased by 7.1–24.2%. The LS volume receiving 40Gy showed the highest decrease (about 31.2%, p < 0.05) in IMRT (OC + LS) plans. On the other hand, in comparison with IMRT (BM), IMRT (OC) reduced the dose volume of to the OC, but increased the dose to LS while IMRT (OC + LS) plans reduced both the OC and the LS volume at all dose levels. Specifically, the V(20) of OC and LS in the IMRT (OC + LS) plan decreased by 11.5 and 11.2%, respectively. CONCLUSION: By introducing the os coxae and lumbosacral spine as the dose–volume constraints, the IMRT plans exhibited the best sparing of the bone marrow without compromising the dose to surrounding normal structures. Therefore, we recommend adding the os coxae and lumbosacral spine as the BM OAR in such plans. BioMed Central 2019-08-05 /pmc/articles/PMC6681496/ /pubmed/31378200 http://dx.doi.org/10.1186/s13014-019-1324-y Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Bao, Zhirong
Wang, Dajiang
Chen, Shupeng
Chen, Min
Jiang, Dazhen
Yang, Chunxu
Liu, Hui
Dai, Jing
Xie, Conghua
Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer
title Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer
title_full Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer
title_fullStr Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer
title_full_unstemmed Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer
title_short Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer
title_sort optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681496/
https://www.ncbi.nlm.nih.gov/pubmed/31378200
http://dx.doi.org/10.1186/s13014-019-1324-y
work_keys_str_mv AT baozhirong optimaldoselimitationstrategyforbonemarrowsparinginintensitymodulatedradiotherapyofcervicalcancer
AT wangdajiang optimaldoselimitationstrategyforbonemarrowsparinginintensitymodulatedradiotherapyofcervicalcancer
AT chenshupeng optimaldoselimitationstrategyforbonemarrowsparinginintensitymodulatedradiotherapyofcervicalcancer
AT chenmin optimaldoselimitationstrategyforbonemarrowsparinginintensitymodulatedradiotherapyofcervicalcancer
AT jiangdazhen optimaldoselimitationstrategyforbonemarrowsparinginintensitymodulatedradiotherapyofcervicalcancer
AT yangchunxu optimaldoselimitationstrategyforbonemarrowsparinginintensitymodulatedradiotherapyofcervicalcancer
AT liuhui optimaldoselimitationstrategyforbonemarrowsparinginintensitymodulatedradiotherapyofcervicalcancer
AT daijing optimaldoselimitationstrategyforbonemarrowsparinginintensitymodulatedradiotherapyofcervicalcancer
AT xieconghua optimaldoselimitationstrategyforbonemarrowsparinginintensitymodulatedradiotherapyofcervicalcancer